Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanny Rialland

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|December 20, 2024
[Vaccination of children and adolescents treated for acute leukemia, excluding HSCT recipients: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)]Aphaia Roussel, Camille Léglise, Fanny Rialland, et al.
Bone Marrow Transplantation|August 26, 2022
Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trialFanny Rialland, Audrey Grain, Myriam Labopin, et al.
Bulletin Du Cancer|July 21, 2022
[Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)]Paul Saultier, Mathieu Simonin, Tiphaine Adam de Beaumais, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignanciesXavier Cahu, Fanny Rialland, Cyrille Touzeau, et al.
Blood|July 24, 2024
Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 studyFranco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, et al.
Bulletin Du Cancer|May 10, 2021
[Management of patients developing acute gastro-intestinal graft-versus-host-disease: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Eva de Berranger, Amandine Charbonnier, Elise Davy, et al.
Transplantation and Cellular Therapy|August 24, 2022
Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical TrialAnne-Charlotte Teyssier, Gérard Michel, Charlotte Jubert, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Growth deceleration in children treated with imatinib for chronic myeloid leukaemiaFrédéric Millot, Joelle Guilhot, André Baruchel, et al.
Bone Marrow Transplantation|March 7, 2024
Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter studyVéronique Houdouin, Jean Christophe Dubus, Sophie Guilmin Crepon, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|December 20, 2024
[Vaccination of children and adolescents treated for acute leukemia, excluding HSCT recipients: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)]Aphaia Roussel, Camille Léglise, Fanny Rialland, et al.
Bone Marrow Transplantation|August 26, 2022
Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trialFanny Rialland, Audrey Grain, Myriam Labopin, et al.
Bulletin Du Cancer|July 21, 2022
[Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)]Paul Saultier, Mathieu Simonin, Tiphaine Adam de Beaumais, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignanciesXavier Cahu, Fanny Rialland, Cyrille Touzeau, et al.
Blood|July 24, 2024
Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 studyFranco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, et al.
Bulletin Du Cancer|May 10, 2021
[Management of patients developing acute gastro-intestinal graft-versus-host-disease: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Eva de Berranger, Amandine Charbonnier, Elise Davy, et al.
Transplantation and Cellular Therapy|August 24, 2022
Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical TrialAnne-Charlotte Teyssier, Gérard Michel, Charlotte Jubert, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Growth deceleration in children treated with imatinib for chronic myeloid leukaemiaFrédéric Millot, Joelle Guilhot, André Baruchel, et al.
Bone Marrow Transplantation|March 7, 2024
Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter studyVéronique Houdouin, Jean Christophe Dubus, Sophie Guilmin Crepon, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
Pageof 6